Pictet Asset Management (Switzerland)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-806,987	Closed	-$16.3M	–	1833
2021 Q3	$16.3M	Buy	+806,987	New	+$22.3M	0.02%	563

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s DRNA Position: Q4 2021 in Review

Pictet Asset Management (Switzerland) sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 806,987 shares — an estimated $16.3M sold.

Pictet Asset Management (Switzerland) first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $16.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Pictet Asset Management (Switzerland) reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 806,987 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $16.3M.
Pictet Asset Management (Switzerland) first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
Pictet Asset Management (Switzerland)'s Dicerna Pharmaceuticals, Inc. position peaked at $16.3M in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 10 Feb 2022.